Cargando…
Activation of GSK‐3 disrupts cholinergic homoeostasis in nucleus basalis of Meynert and frontal cortex of rats
The cholinergic impairment is an early marker in Alzheimer's disease (AD), while the mechanisms are not fully understood. We investigated here the effects of glycogen synthase kinse‐3 (GSK‐3) activation on the cholinergic homoeostasis in nucleus basalis of Meynert (NBM) and frontal cortex, the...
Autores principales: | Wang, Yue, Tian, Qing, Liu, En‐Jie, Zhao, Li, Song, Jie, Liu, Xin‐An, Ren, Qing‐Guo, Jiang, Xia, Zeng, Juan, Yang, Yu‐Tao, Wang, Jian‐Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706587/ https://www.ncbi.nlm.nih.gov/pubmed/28656644 http://dx.doi.org/10.1111/jcmm.13262 |
Ejemplares similares
-
Neuropsychiatric symptoms of cholinergic deficiency occur with degradation of the projections from the nucleus basalis of Meynert
por: van Dalen, Jan Willem, et al.
Publicado: (2016) -
Yokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert
por: Tabuchi, Masahiro, et al.
Publicado: (2017) -
Nucleus Basalis of Meynert Stimulation for Dementia: Theoretical and Technical Considerations
por: Kumbhare, Deepak, et al.
Publicado: (2018) -
An Individualized Tractography Pipeline for the Nucleus Basalis of Meynert Lateral Tract
por: Crockett, Rachel A., et al.
Publicado: (2023) -
Potential for intermittent stimulation of nucleus basalis of Meynert to impact treatment of alzheimer's disease
por: Blake, David T., et al.
Publicado: (2017)